Literature DB >> 8647957

Studies of the expression of the Wiskott-Aldrich syndrome protein.

D M Stewart1, S Treiber-Held, C C Kurman, F Facchetti, L D Notarangelo, D L Nelson.   

Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by thrombocytopenia, eczema, disorders in cell-mediated and humoral immunity, and a proclivity to lymphoproliferative disease. The gene responsible encodes a 53-kD proline-rich protein of unknown function (WASP). We produced a FLAG-WASP fusion protein that was used to immunize mice and produce mAbs against WASP. Using monoclonal anti-WASP in Western immunoblots, we have determined that WASP is present in the cytoplasmic but not nuclear fraction of normal human peripheral blood mononuclear cells, in normal human platelets, in T lymphocytes, non-T lymphocytes, and monocytes. The protein is produced in the B cell immunoblastic cell line DS-1, in normal EBV-transformed B cell lines, and in HEL92.1.7, but is barely detectable in MOLT-4 and not detectable in K562. WASP was present in two of four EBV-transformed cell lines from WAS patients. Splenic tissue immunostaining was performed in two patients, and the results correlated with the results of the Western blots. Sequence analysis of WASP cDNA from two patients who produce WASP show mutations causing amino acid substitutions. These studies establish a foundation for further studies aimed at understanding the function of WASP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647957      PMCID: PMC507350          DOI: 10.1172/JCI118712

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure.

Authors:  L Corash; H Tan; H R Gralnick
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

2.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets.

Authors:  H D Ochs; S J Slichter; L A Harker; W E Von Behrens; R A Clark; R J Wedgwood
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

3.  Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function.

Authors:  D G Poplack; G D Bonnard; B J Holiman; R M Blaese
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

4.  Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro.

Authors:  A Aldovini; C Debouck; M B Feinberg; M Rosenberg; S K Arya; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation.

Authors:  W L Greer; E Higgins; D R Sutherland; A Novogrodsky; I Brockhausen; M Peacocke; L A Rubin; M Baker; J W Dennis; K A Siminovitch
Journal:  Biochem Cell Biol       Date:  1989-09       Impact factor: 3.626

6.  Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional.

Authors:  B Ferguson; N Jones; J Richter; M Rosenberg
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

7.  Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome.

Authors:  R Parkman; E Remold-O'Donnell; D M Kenney; S Perrine; F S Rosen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

8.  Expression and characterization of the human c-myc DNA-binding protein.

Authors:  R A Watt; A R Shatzman; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

9.  Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.

Authors:  C Van Beveren; F van Straaten; T Curran; R Müller; I M Verma
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

10.  Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.

Authors:  R Yarchoan; G Tosato; R M Blaese; R M Simon; D L Nelson
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  26 in total

1.  A WASp-VASP complex regulates actin polymerization at the plasma membrane.

Authors:  F Castellano; C Le Clainche; D Patin; M F Carlier; P Chavrier
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

2.  Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.

Authors:  Nikolay P Nikolov; Masaki Shimizu; Sophia Cleland; Daniel Bailey; Joseph Aoki; Ted Strom; Pamela L Schwartzberg; Fabio Candotti; Richard M Siegel
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

3.  Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.

Authors:  T Wada; S H Schurman; M Otsu; E K Garabedian; H D Ochs; D L Nelson; F Candotti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation: evidence that WIP-WASP dissociation is not required and that the WIP NH2 terminus is inhibitory.

Authors:  Xiaoyun Dong; Genaro Patino-Lopez; Fabio Candotti; Stephen Shaw
Journal:  J Biol Chem       Date:  2007-08-20       Impact factor: 5.157

5.  Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome.

Authors:  Taizo Wada; Shepherd H Schurman; Elizabeth K Garabedian; Akihiro Yachie; Fabio Candotti
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

6.  Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages.

Authors:  S Linder; D Nelson; M Weiss; M Aepfelbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

7.  Clinical aspects and genetic analysis of taiwanese patients with wiskott-Aldrich syndrome protein mutation: the first identification of x-linked thrombocytopenia in the chinese with novel mutations.

Authors:  Wen-I Lee; Jing-Long Huang; Tang-Her Jaing; Kang-Hsi Wu; Yin-Hsiu Chien; Kuei-Wen Chang
Journal:  J Clin Immunol       Date:  2010-03-16       Impact factor: 8.317

8.  Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex.

Authors:  S Linder; C Heimerl; V Fingerle; M Aepfelbacher; B Wilske
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

Authors:  Taizo Wada; Akihiro Konno; Shepherd H Schurman; Elizabeth K Garabedian; Stacie M Anderson; Martha Kirby; David L Nelson; Fabio Candotti
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

10.  Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.

Authors:  Anja J Gerrits; Emily A Leven; Andrew L Frelinger; Sophie L Brigstocke; Michelle A Berny-Lang; W Beau Mitchell; Shoshana Revel-Vilk; Hannah Tamary; Sabrina L Carmichael; Marc R Barnard; Alan D Michelson; James B Bussel
Journal:  Blood       Date:  2015-07-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.